Analogous to AGs, the MAL erythromycin has also been used as a therapeutic TRID, in particular for treatment of familial adenomatous polyposis to repair PTC sequence variants in the APC (adenomatous polyposis coli) gene (Kariv et al, 2020). Here, TNFRSF10C is linked to Familial adenomatous polyposis.